NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » Companies » Rousselot Biomedical

Rousselot Biomedical - advancing medical science

About Rousselot Biomedical

As the most recent strategic business segment within Rousselot® - the world leading manufacturer of collagen-based solutions – Rousselot Biomedical drawn upon 130 years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop innovative ranges of purified, modified and non-modified gelatins and collagens for biomedical applications.


Contact Rousselot Biomedical

Videos

With Rousselot X-Pure modified gelatins you can focus on what is truly important for you, achieving reproducible and consistent data. Watch our video to find out how we can help you get your research published faster.

Endotoxins can slow the pace of scientific progress for biomedical applications in tissue engineering and regenerative medicines.

Endotoxins are slowing the pace of scientific progress for biomedical applications in tissue engineering and regenerative medicines – here’s how.

ABOUT Rousselot Biomedical


SECTOR: Company Insight

As the most recent strategic business segment within Rousselot® - the world leading manufacturer of collagen-based solutions – Rousselot Biomedical drawn upon 130 years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop innovative ranges of purified, modified and non-modified gelatins and collagens for biomedical applications.

X-Pure®: A world-class range of customizable low-endotoxin gelatins and collagens for in vitro and in vivo applications
Offering unique advantages to assure performance, quality and safety, X-Pure products are customizable and include X-Pure GelatinX-Pure GelMA, and X-Pure GelDAT®. With ultra-low impurity levels, X-Pure offers maximum quality and safety and provides exciting possibilities for research & development of biomedical applications.

X-Pure is ideal for 3D printing, tissue engineering, regenerative medicine, vaccines, drug delivery systems, cell therapies, surgical and parenteral applications, wound healing and organ on a chip.

New Quali-Pure® range of pharmaceutical gelatins
Specifically designed to support biomedical application areas including embolization, wound healing, drug delivery, vaccines and hemostatics, Quali-Pure® delivers biocompatibility, biodegradability, controlled endotoxin levels, and batch-to-batch consistency.

All Rousselot biomedical gelatins are GMP* ready and fully documented to support medical device compliance with ISO standards and the new EU Medical Device Regulation (MDR).

Rousselot Biomedical is committed to engineer, accelerate and scale superior products helping transform ideas into biomedical solutions around the world using our scientific expertise and collaborative approach to support end-to-end partnerships and to “Advance medical science”.

Rousselot BV

Kanaaldijk Noord 20

5691 NM SON

The Netherlands

Phone: +31 499 364100

For more information please visit: www.rousselot.com/biomedical

Contact Rousselot Biomedical
X-Pure® Gelatins

X-Pure® is a range of premium-grade gelatins, with tunable functionalities in addition to high-purity ≤10EU/g. X-Pure gelatins are optimized for in-vivo or in-vitro research and clinical applications and produced under GMP conditions. They can be designed or customized to provide significant technical advantages for the development of biomedical applications.

X-Pure® GelMA

Due to its excellent biocompatibility, biodegradability, and tunability, Gelatin methacryloyl (GelMA) is probably the most popular biomaterial used in 3D bioprinting, tissue engineering and 3D cell culture applications.

X-Pure® GelDAT®

X-Pure® GelDAT is the world’s first purified Gelatin Desaminotyrosine. X-Pure GelDAT hydrogels are ideal for research and preclinical development in regenerative medicine, drug release and complex wound dressings due to their ability to crosslink with tissues and their purity.

Quali-Pure® range of pharmaceutical gelatins

Quali-Pure® is a range of pharmaceutical gelatins, that has been specifically designed to support biomedical application areas including embolization, wound healing, drug delivery, vaccines and hemostatics.

Contact Rousselot Biomedical
The unique properties of gelatin in 3D bioprinting

3D bioprinting is a very popular tissue engineering technology used in the field of regenerative medicine. However, to create successful tissue constructs, it is of critical importance to select suitable biomaterials. In this whitepaper, we explore the benefits of using gelatin as a bioink in various 3D bioprinting technologies, and describe how the low endotoxin gelatins in the X-Pure® assortment – a range of highly purified gelatins – can help secure proper cellular characteristics and functionalities, and enable (bio) medical applications with low immunogenicity.

Download White Paper
The mutiple benefits of highly purified gelatins in parenteral applications

Can ultra-pure GMP grade gelatins help support faster and simpler development of parenteral formulations, including vaccines? As a biomaterial of choice, pharmaceutical gelatin is widely recognized for its use in parenteral applications. Highly biocompatible, purified gelatin helps provide drug protection, offers superior drug loading rates, and great flexibility in the control of drug release. It helps stabilize vaccines and other formulations and minimizes side reactions while ensuring patient safety. These are just few examples of the many benefits provided by purified gelatins. This white paper explores these various advantages and describes how X-Pure® extra purified GMP quality gelatins can help realize superior parenteral formulations.

Download White Paper
Gelatin for safe micro- and submicron particle applications

Gelatin-based micro- and submicron particles have gained increased interest in the fields of drug delivery and regenerative medicine. However, these micro- and submicron particle formulations can contain endotoxins, which is a safety challenge in these specific applications. A new and ultra-pure gelatin, X-Pure, is now available for preparing gelatin micro- and submicron particles with exceptionally low endotoxin levels. This white paper provides background information on gelatin-based micro- and submicron particles properties and application examples.

Download White Paper
Rousselot low endotoxin gelatins and collagens for biomedical applications

This whitepaper outlines the benefits of gelatin and collagen for (bio)medical applications and highlights the importance of low endotoxin levels for optimal API (Active Pharmaceutical Ingredients) delivery and (bio)medical engineering materials. The paper also highlights the value-added expertise that Rousselot can offer to researchers, developpers and manufacturers of (bio)medical applications of gelatin, hydrolyzed gelatin and collagen.

Download White Paper
Contact Rousselot Biomedical
Rousselot® Biomedical announces the launch of Quali-Pure HGP 2000

Irving, United States, May 4 2022 / Sciad Newswire / Rousselot®, Darling Ingredients’ health brand and the global leader of collagen-based solutions1, launches Quali-Pure™ HGP 2000, a new endotoxin-controlled, pharmaceutical-grade gelatin specifically designed for vaccines and wound healing applications. As the latest addition to Rousselot Biomedical’s rapidly expanding product offering, this new non-gelling hydrolyzed gelatin further extends the scope of biomedical applications covered by Rousselot products.

Rousselot Biomedical announces the world’s first GelMA produced under GMP

Irving, United States, 13th April 2022 / Sciad Newswire / Rousselot®, Darling Ingredients’ health brand, and the global leader of collagen-based solutions1 announces the launch of GMP grade GelMA. X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions2.

Contact Rousselot Biomedical
Contact Rousselot Biomedical
Contact Rousselot Biomedical
Contact Rousselot Biomedical

Rousselot Biomedical - advancing medical science

As the most recent strategic business segment within Rousselot® -...